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Objective. The aim of this study was to compare the prevalence of Candida spp. in diabetics and nondiabetics with
and without denture stomatitis (DS).
Study design. Mycologic samples were taken from the dentures of 90 healthy subjects (control group [CG]), 80
denture stomatitis nondiabetics (DSND), and 40 denture stomatitis diabetics (DSD; well controlled type 2) for
identification of Candida spp. Results were analyzed by Fisher exact test, Bonferroni-corrected confidence interval, and
2 test (  .05).
Results. Candida albicans was the predominant species isolated (81.9%; P  .016), with C. tropicalis and C. glabrata
demonstrating similar prevalence (15.71% and 15.24%, respectively). The prevalence of C. albicans and C. tropicalis
in the DS groups were significantly higher (P  .01) than in the CG. The prevalence of C. tropicalis significantly
increased with the highest degree of inflammation (P  .05).
Conclusions. The prevalence of Candida spp. was similar between diabetic and nondiabetic patients with DS.
Candida tropicalis may play a role in the progression of DS. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2011;111:726-733)Diabetes mellitus is a chronic metabolic disorder that is
becoming one of the most important chronic diseases
worldwide. It has been estimated that the number of
adults with diabetes in the world will rise to 300 million
by the year 2025.1 The relationship between diabetes
and oral candidiasis has been extensively studied in the
literature,2-13 particularly because diabetic patients are
more susceptible to fungal infections than those without
diabetes.2-4,10 Yeast adhesion to epithelial cell surfaces
is recognized as an essential first step in the process of
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726candidal colonization and subsequent infection.14 Sali-
vary glucose levels in diabetic patients favors yeast
growth owing to increased numbers of available recep-
tors for Candida.15 Consequently, buccal cells from
diabetic patients have shown an increased adherence of
C. albicans compared with buccal cells from nondia-
betics.3,4 The microvascular degeneration found in his-
tologic examination of diabetic patients may also pre-
dispose to Candida colonization,16 making them more
susceptible to infections. Another host factor that may
promote the oral carriage of Candida in diabetics is the
possible defects in candidacidal activity of neutrophils,
particularly in the presence of glucose.17 Reduced sal-
ivary flow, associated with diabetes, may also play a
role in Candida colonization and, consequently, in the
pathogenesis of oral candidiasis in these patients.8
The presence of a denture in the oral cavity, associ-
ated with the local alterations of the oral mucosa and
the systemic complications, may render the denture
wearer patient with diabetes even more prone to can-
didal infection.4,5,7,10,11 A significantly higher inci-
dence of Candida infection and increased levels of
Candida spp. were found in diabetic patients wearing
removable dentures.7,10,11 The presence of a removable
denture may decrease the salivary pH and saliva flow
rate and impede the mechanical cleaning of the soft
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induced trauma may reduce tissue resistance against
infection because of the increase in permeability of the
epithelium to soluble candidal antigens and toxins.19
Moreover, the tissue surface of the acrylic resin denture
acts as a reservoir that harbors microorganisms, en-
hancing their infective potential and aggravating a pre-
viously existing condition.14,18 For this reason, both
systemic and local predisposing factors might promote
an increase in the number of microorganisms and there-
fore the risk of oral candidiasis in diabetics, especially
in those patients wearing removable dentures.
Different Candida species have been frequently iso-
lated from the oral cavities of patients with diabetes.
Candida albicans is the most commonly recovered
species in diabetic patients, with a prevalence of up to
80%.2,3,5,11 This oral fungal pathogen is the most
virulent of the Candida species20 and is able to grow as
biofilm, which consists of a complex community of
cells embedded in a matrix of extracellular polysaccha-
ride.21 These cells exhibit distinctive phenotypic prop-
erties from planktonic cells and increased resistance to
antimicrobial agents.21,22 The epidemiology of Can-
dida infections has changed with emergence of non-
albicans species which have been increasingly de-
scribed in both compromised and noncompromised
hosts.2-7,9-13,23-27 Non-albicans species have been con-
sistently observed in diabetes patients2-7,9-13 and in
those with denture stomatitis.23-27 Multiple isolations
of Candida species, including C. albicans, C. glabrata,
C. tropicalis, C. famata, C. krusei, C. kefyr, C. collicu-
losa, C. parapsilosis, C. guillermondii, and C. rugosa
were recorded in diabetes patients.2,4-7,9,11,12 Candida
dubliniensis has also been isolated from the oral cavi-
ties of diabetes patients.11,13 In addition, diabetes pa-
tients with dentures had more non-albicans Candida
species isolated than dentate diabetes patients.6,9-11
Similar findings have been observed in nondiabetic
denture-wearing patients with denture stomatitis, where
C. tropicalis and C. glabrata were the non-albicans
species most often isolated.23,25,27
A number of yeast-related factors, such as adhesion
to host cells and acrylic surfaces,20,28-31 cell-surface
hydrophobicity,28,31-33 and secretion of several degra-
dative enzymes,12,20,29,34 are recognized to promote the
virulence of Candida spp. and may explain the changes
in Candida infection epidemiology. Another important
factor related to these different species of Candida is
the development of drug resistance. Along with this
species diversity and long-term administration of med-
ications, strains with elevated virulence and acquired
resistance against antifungal drugs might colonize the
oral cavity.35,36 Studies have demonstrated that the
widespread use of medications, especially azoles, haspromoted selection of resistant species by shifting col-
onization to more naturally resistant Candida species,
such as C. glabrata, C. dubliniensis, and C. krusei.35,36
The emergence of resistance among Candida isolates to
currently available antifungal drugs, associated with
epidemiologic changes in Candida flora, has important
implications for mortality.37-44 It has been demon-
strated that 90% of fungemia cases are attributable to
Candida species37,38 and that the number of deaths as a
result of fungemia has ranged from 40% to almost
80% in immunocompromised hosts.37-43 In addition, a
high crude mortality was also observed among nonim-
munocompromised patients (60%)40 and those with
diabetes (67%).39 Candida tropicalis has been reported
to be one of the leading Candida species other than C.
albicans to cause fungemia.38,39,41,43,44 Therefore, ac-
curate identification and the evaluation of the clinical
prevalence of Candida spp. in specific groups of pa-
tients are essential to determine strategies for control
and management of oral candidal infection and thus to
improve the mortality rate associated with this infec-
tion. Although there have been numerous studies eval-
uating the prevalence of Candida spp. in different
groups of patients,2,3,5-11,13,14,23-27 there have been only
a few studies4,12 that compared the prevalence in den-
ture wearers meeting specific criteria for type 2 diabetes
and denture stomatitis with that in nondiabetic denture
wearers with denture stomatitis. Therefore, the aim of
the present cross-sectional study was to compare the
prevalence of Candida spp. in well controlled type 2
diabetic and nondiabetic denture-wearing patients with
and without denture stomatitis.
SUBJECTS AND METHODS
Subjects
In the present study, subjects were selected either
from staff and patients of the São Paulo State Univer-
sity, Araraquara Dental School, or recruited from the
general population of the Araraquara metropolitan area.
Individuals who had received or were currently receiv-
ing treatment with antibiotics, antifungals, or steroids in
the past 3 months; patients with anemia, immunosup-
pression or cancer therapy (radio- or chemotherapy);
and those wearing the same denture for30 years were
excluded. A total of 210 voluntary patients were se-
lected to participate in the study. The protocol of the
project was approved by the Ethics Committee of the
Araraquara Dental School (06/2006—0004.0.199.
174-06 SISNEP), and each subject signed an informed
consent form. Personal, medical, and dental histories of
the patients (age and gender of the patients, medication
use, smoking habit, and denture age) were recorded.
Two risk factors for denture stomatitis were considered
OOOOE
728 Sanitá et al. June 2011in this study: the age of the dentures45 and smoking
habit.6,46
A comprehensive oral examination of the 210 pa-
tients was performed by the same investigator, who was
blinded to all clinical information and the diabetic state
of the subjects, and their mucosal characteristics were
classified according to the criteria proposed by New-
ton47: 0, absence of palatal inflammation; 1 (type I),
petechiae dispersed throughout all or any part of palatal
mucosa in contact with the denture (localized simple
inflammation); 2 (type II), macular erythema without
hyperplasia (generalized simple inflammation); and 3
(type III), diffuse or generalized erythema with papil-
lary hyperplasia (inflammatory papillary hyperplasia).
According to the systemic condition of the patients
and the characteristics of their palatal mucosa, the
210 volunteers were divided into 3 groups of study:
control group (CG), 90 individuals without diabetes
and with healthy palatal mucosa; 80 nondiabetic
patients diagnosed with denture stomatitis according
to Newton’s criteria47 (DSND); and 40 diabetic pa-
tients with denture stomatitis according to Newton’s
criteria47 (DSD).
Diabetic patients were evaluated in relation to their
medical care of diabetes, and only those with well
controlled type 2 diabetes were selected. Based on the
recommendations of the “Standards of Medical Care in
Diabetes” (2007),48 4 clinical chemistry tests were used
to assess the degree of diabetic control: fasting blood
glucose level, postprandial capillary plasma glucose,
glycosylated hemoglobin level, and serum lipids. Se-
rum creatinine and urine tests were also assessed to
evaluate the systemic health condition of the diabetic
individuals. All tests were taken before clinical and
mycologic procedures. Only patients fulfilling the rec-
Table I. Summary of recommendations for adults with
diabetes48
Test Goal value
Fasting blood glucose level 90-130 mg/dL
Postprandial capillary plasma glucose 180 mg/dL
Glycosylated hemoglobin level 7%
Serum lipids
Low-density lipoprotein 100 mg/dL
Triglycerides 150 mg/dL
High-density lipoprotein 40 mg/dL
Serum creatinine 0.4-1.3 mg/dL
Urine
Protein Absent
Glucose Absent
Nitrite Absent
Leukocytes 10 U/mm3ommended goals for the tests (Table I) were selected.Clinical and mycologic procedures
Oral swab samples were collected from the tissue
surface of the upper denture of all patients.9,23,25,26
Each swab was placed into a test tube containing 5 mL
of 0.9% sterile saline solution and vortexed for 1 min-
ute to suspend the organisms from the swab. An aliquot
(50 L) from this suspension was spread-plated on
Chromagar Candida2,9,10,23,25,26 and incubated at 30°C
for 5 days. Colonies were presumptively identified by
colony color. Thereafter, biochemical tests were per-
formed to confirm all identifications. One colony of
each color type on Chromagar Candida was transfered
onto fresh Sabouraud dextrose agar for purity. After 48
hours at 37°C, yeast isolates were identified by using
the following biochemical tests: carbohydrate assimila-
tion pattern using the API ID32C system (Biomérieux,
Marcy-l’Etoile, France) and morphologic characteris-
tics produced on corn meal agar with Tween-80. In
addition, green colonies on Chromagar Candida were
submitted to hypertonic Sabouraud broth test for dis-
criminating C. albicans and C. dubliniensis.49
Statistical analyses
Demographic characteristics of the patients and the
risk factors were statistically analyzed to ensure homo-
geneity between the groups by means of 1-way analysis
of variance followed by Tukey post hoc test (age of
patients), Kruskal-Wallis followed by Dunns multiple-
comparisons test (age of dentures), and Fisher exact test
(gender and smoking habit). Bonferroni-corrected con-
fidence interval, Fisher exact test, and 2 analysis of
several proportions were used to compare the percent-
age of different species of Candida among experimen-
tal groups, the percentage of diabetics and nondiabetics
in relation to the Newton types of denture stomatitis,
and the distribution of Candida spp. in relation to
Newton classification. Differences were considered to
be statistically significant at P  .05.
RESULTS
The demographic characteristics of the 210 complete
denture wearer patients and the risk factors for denture
stomatitis are described in Table II. The mean age of
the patients was 62.5 years (range 59.6-65.5 years) at
the time of the initial evaluation. In all groups, the
number of female patients was more than 3 times
higher than that of male patients, with no significant
differences among the groups (P  .247). Patients in
CG had their dentures placed more recently than those
in DSND and DSD (Dunn multiple-comparisons test:
P  .0001). Few smokers participated in this study and
no significant differences were found in their distribu-
tion among the 3 groups of study (P  .910).
rent (P
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was the predominant yeast, isolated from 81.9% of the
participants (P  .016 [after Bonferroni correction]).
Candida glabrata and C. tropicalis were isolated from
15.71% and 15.24% of the 210 participants, respec-
tively, with no statistical differences between them
(P  .05; Bonferroni-corrected 95% confidence inter-
vals: C. albicans 0.75-0.88; C. tropicalis 0.08-0.19; and
C. glabrata 0.09-0.20). When the distribution of Can-
dida spp. within each group was analyzed (Table III),
C. albicans was also the predominant yeast in all
groups (P  .016 [after Bonferroni correction]). Re-
gardless of the group, C. glabrata and C. tropicalis
were the nonalbicans species most frequently isolated,
with no significant differences between them (P .05).
The percentage frequencies of C. albicans and C. tropi-
calis in the denture stomatitis groups (DSND and DSD)
were significantly higher than those in CG (2 test: P
.01), whereas there were no significant differences in
the percentage of frequency of C. glabrata observed in
the 3 groups of patients (P  .05).
Twenty percent of DSND and 38% of DSD patients
had Newton type I, 61% and 53%, respectively, had
Newton type II, and 19% and 10% had Newton type III,
with no significant differences between groups of pa-
tients (Fisher exact test: P  .09). Because no signifi-
cant differences were found between the 2 groups of
patients with denture stomatitis, regarding either Can-
dida spp. prevalence or Newton types, patients were
pooled and the frequency distribution of Candida spp.
in the different types of denture stomatitis was evalu-
ated. The 2 test for the comparison of several propor-
tions revealed that the frequency distribution of C.
tropicalis significantly increased (P  .01) relative to
the highest degree of inflammation (Table IV). The
prevalences of C. albicans (P .4015) and C. glabrata
(P  .2939) were not influenced by the degree of
inflammation.
Several study participants had1 species of yeast on
the denture surfaces. For the 210 patients sampled,
yeast mixtures isolated were C. albicans  C. glabrata
Table II. Descriptive analysis of demographic charact
Demographic characteristics
Mean age (y) Gender (%
CG (n  90) 65.5a 72.3a
DSND (n  80) 59.6b 77.5a
DSD (n  40) 62.4ab 87.5a
P value .0002* .24
CG, healthy control group; DSND, denture stomatitis without diabet
*One-way analysis of variance; †Kruskal-Wallis test; ‡Fisher exact
a,bIn columns, values with the same letter were not statistically diffe(40.4%), C. albicans  C. tropicalis (36.5%), and C.albicans  C. glabrata  C. tropicalis (19.2%). The
frequency distribution of mixed species populations
observed in CG (14.4%) was significantly lower (P 
.01) than that observed in the 120 patients with denture
stomatitis (32.5%).
DISCUSSION
A higher percentage of female patients was observed
in the present investigation, and this result agrees with
previous studies.7,10,24 It has been found that elderly
women presented more oral lesions than men50 and that
the hormonal factor and the great incidence of iron
deficiency in women could be responsible for that dis-
parity.18,51 In addition, this difference can be explained
by the fact that women seek dental treatment at a higher
rate than men.52 The mean age of the dentures, in CG,
was considered to be satisfactory (4.5 years old) and
was lower than in DSND (15.1 years old) and DSD
(13.7 years old). The age of dentures has been related to
the occurrence of denture stomatitis.45 Moreover, tissue
trauma, frequently present in patients with poorly fit-
ting dentures and nonbalanced occlusion, can affect the
occurrence of this infection.51 Old dentures are also
Table III. Frequency distribution (%) of Candida spp.
in relation to the groups of study
CG DSND DSD
C. albicans 64a 93b 100b
C. tropicalis 2a 28b 20b
C. glabrata 14a 20a 10a
Values for C. tropicalis and C. glabrata were not significantly
different (P  .05; Bonferroni-corrected 95% confidence intervals:
CG: C. albicans 0.51-0.76, C. tropicalis 0.001-0.09, and C. glabrata
0.07-0.25; DSND: C. albicans 0.82-0.98, C. tropicalis 0.16-0.41, and
C. glabrata 0.10-0.33; and DSD: C. albicans .89-01.0, C. tropicalis
0.07-0.40, and C. glabrata 0.02-0.27).
Abbreviations as in Table II.
a,bIn rows, values with the same letter were not statistically different
(2 test: P  .05).
s and risk factors
Risk factors
) Mean age of dentures (y) % nonsmokers
4.5a 86.7a
15.1b 85.0a
13.7b 87.5a
.0001† .910‡
, denture stomatitis with diabetes.
 .05).eristic
female
7‡
es; DSD
test.more difficult to keep clean because of the greater
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Candida colonization. Therefore, it is reasonable to
suppose that patients of DSND and DSD were more
susceptible to denture stomatitis than those of CG.
Smoking habit has also been found to be an important
local factor in oral candidiasis.6,46 Tobacco smoking
associated with denture friction on the oral mucosa
alters the mucosal surface, leading to contamination by
Candida spp.46 However, the percentage of nonsmok-
ers in all groups of this study was considerably high;
therefore, it is difficult to ascertain the influence of this
risk factor on the outcomes determined in this study.
Not surprisingly, of the 210 patients evaluated,
81.9% (172 patients) harbored C. albicans, which was
by far the predominant yeast isolated. This finding is in
agreement with earlier reports.2,3,5,9,11,12,23,26 Candida
albicans was also isolated from 64% of the patients
without denture stomatitis, which was increased to 93%
and 100% in the groups of denture stomatitis patients
(DSND and DSD, respectively). In agreement with
these results, Coco et al.23 demonstrated that C. albi-
cans was isolated from 75% of patients without denture
stomatitis and from 81% of those with clinical signs of
the infection. Candida albicans expresses several vir-
ulence factors that contribute to its pathogenesis and
very high prevalence. These factors include host rec-
ognition biomolecules (adhesins), morphogenesis (the
reversible transition between unicellular yeast cells and
filamentous growth forms), and aspartyl protease and
phospholipase production.20,29 Phenotypic switching is
accompanied by changes in antigen expression, colony
morphology, and tissue affinities in C. albicans, which
might provide cells with a flexibility that results in the
adaptation of the organism to the hostile conditions
imposed by the host and treatment modality.20 In ad-
dition, C. albicans has the ability to adhere to mucosal
and denture surfaces, which is considered to be the first
step in the pathogenesis of denture stomatitis.14
Although C. albicans is still the most frequently
isolated species from patients with Candida infec-
tions,2-6,9,11-13,23-27 the growing prevalence of non-al-
bicans species is clearly a concern. In the present study,
C. glabrata and C. tropicalis were isolated from
Table IV. Frequency distribution (%) of Candida spp.
in different types of denture stomatitis
Type 1 Type 2 Type 3 P value
C. albicans 100 94.3 94.7 .4015
C. tropicalis 25.8 18.6 57.9 .01
C. glabrata 9.7 15.7 26.3 .2939
Significant difference only between types 2 and 3 for C. tropicalis.15.71% and 15.24% of healthy and denture stomatitispatients, respectively. Vanden Abbeele et al.26 also
observed that C. albicans was the commonest yeast
found on patients’ dentures, followed by C. glabrata
and C. tropicalis. In another study, C. albicans, C.
glabrata, and C. tropicalis represented 80% of isolates
from clinical infections.10 In terms of frequency distribu-
tion, some studies have shown that C. tropicalis was the
second most prevalent species identified.5,9,24,25 However,
contrasting results have been found in other studies, in
which C. glabrata was the most common yeast after C.
albicans.4,6,23,26,27 In the present investigation, there were
no significant differences between the prevalence of C.
tropicalis and C. glabrata in all patient groups. The dif-
ferences in findings among studies are likely to be related
to a combination of factors, such as sample tech-
niques10,23-27 and culture media53 used. Conventional
sampling techniques used in various studies include oral
rinses.7,10,23 Although this sampling technique provides
adequate qualitative information, it can be argued whether
adherent biofilm cells or loosely adherent cells residing at
the peripheries of the biofilm are removed during this
procedure. To overcome this limitation, swabbing of the
denture fitting surfaces was used for sampling in the
present investigation.9,23,25,26 Because Chromagar Can-
dida is generally more sensitive than other media in de-
tecting mixed populations of yeasts,53 this improved cul-
ture medium was used in the present study2,9,10,23,25,26 and
provided differential staining and highlighted colonial
morphologic variations between Candida species, thus
increasing the sensitivity of detection of yeasts.
Furthermore, a large variation in species frequency
has been reported in different regions of the world.54,55
Although several investigators reported that C. tropi-
calis is one of the most common non-albicans species
isolated in Brazil and South America,38,39,41,54,55 the
literature contains substantial data indicating that C.
glabrata is found much more frequently in North
America.54,55 Although these non-albicans species are
in general less virulent than C. albicans,20,30,32-34 it has
been reported that C. tropicalis and C. glabrata have
the ability to cause fungemia in humans41,43,44 and that
they are associated with a higher mortality rate than C.
albicans.38,41,43 Therefore, the pathogenicity of these
species cannot be underestimated and more attention
has to be paid to their appearance. It is important to
mention that, in the present investigation, the species C.
dubliniensis was not detected among any Candida iso-
lates. This result agrees with other studies in which this
species was not found in elderly individuals,24,26 in
denture wearers with and without denture stomati-
tis,23,27,34 or in diabetic patients.2,4,5,7-9,12 However, C.
dubliniensis has been isolated in both diabetic10,11,13
and nondiabetic25 patients. This disparity may be re-
lated to problems with identification techniques, be-
OOOOE
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phenotypic characteristics, making distinction between
them difficult for conventional mycology laboratory
testing. In the present investigation, the fact that only
the hypertonic Sabouraud broth test49 was performed
for the discrimination between these 2 species may be
considered as a limitation of this study. The isolates of
both species produce a green color on Chromagar Can-
dida and chlamydoconidia on corn meal agar with
Tween-80. Therefore, if present, C. dubliniensis iso-
lates could have been misidentified as C. albicans. In
further studies, polymerase chain reaction should be
conducted to facilitate the differential diagnosis be-
tween these 2 species.
In the present study, no significant differences in
Candida spp. prevalence were found between denture
stomatitis patients with and without diabetes. Contrast-
ing results have been reported in earlier studies, in
which diabetic patients were found to be more likely to
have a higher prevalence of Candida spp. than nondia-
betics.2-4,8-10 However, it is important to mention that
either poorly controlled diabetic individuals were in-
cluded in these studies (e.g., patients with glycosylated
hemoglobin level 7% or fasting blood glucose level
130 mg/dL)3,4,9 or the degree of diabetic control was
not reported.2,8,10 In the present investigation, only well
controlled type 2 diabetes patients were included, and
this may help explain the results. All patients with
denture stomatitis were pooled, and the distribution of
the oral yeasts was analyzed in relation to Newton
classification of the infection.47 The results showed that
the frequency distribution of C. tropicalis significantly
increased relative to the highest degree of inflammation
(Table IV). These results, combined with the evidence
for enhanced frequency distribution of C. tropicalis in
DSND and DSD groups (Table III), suggest that the
higher frequency of this species in denture surfaces
may play a role in the progression of denture stomatitis.
It has been suggested that species more resistant to
therapeutic approaches may emerge in patients with
candidiasis, especially those with recurrent infec-
tions.35,36 In addition, C. tropicalis has been demon-
strated to display higher potential for dissemination and
mortality rates than C. albicans and other spe-
cies.38,39,41,43,44 Several studies showed that C. tropi-
calis is one of the most commonly isolated non-albi-
cans species in denture wearers,9,25,26 in patients with
denture stomatitis,25,27 and in diabetes patients with4,12
and without5,7,9,10 denture stomatitis. Although the rea-
son for the increased incidence of C. tropicalis infec-
tions is not completely understood, it could be attrib-
uted to some virulence factors associated with this
species. Different C. tropicalis strains have demon-
strated a high cell-surface hydrophobicity, which isinvolved in the adherence of microorganisms to differ-
ent surfaces and considered to be an important patho-
genic attribute of yeasts.32,33 It has been demonstrated
that C. tropicalis obtained from the oral cavity of
denture wearers with denture stomatitis were more ad-
herent to buccal ephitelial cells than those obtained
from patients without signs of disease.30 Candida tropi-
calis strains seem to grow rapidly in the human body,
because of their high sucrose assimilation ability.56
Other important virulence factor of this species is its
capability to produce degradative enzymes, such as
phospholipase12 and proteinase,12,34 which are directly
correlated to the invasion and destruction of host tis-
sue.20,29 The ability of C. tropicalis strains to form
biofilm on different surfaces57,58 is another potential
virulence trait, which may increase their resistance to
antifungal treatment.21,22 Although these specific viru-
lence factors related to C. tropicalis may help explain
the results obtained in the present study, further inves-
tigations will be required to examine and better under-
stand the mechanism of pathogenicity of this Candida
species.
Several study participants had1 species of yeast on
the denture surfaces. The frequency distribution of
mixed species populations observed in CG (14.4%) was
significantly lower than that observed in the 120 pa-
tients with denture stomatitis (32.5%). The yeast asso-
ciations noted in the present study were C. albicans
together with either C. tropicalis and/or C. glabrata,
confirming trends found at other institutions.2,5,27
Whether these combinations of yeasts contribute to
enhanced pathogenicity remains to be elucidated. The
majority of patients with denture stomatitis had a
chronic disease process that required prolonged and
multiple treatments, which favors the emergence of
other non-albicans species and formation of mixed
biofilms.35,36 Biofilm-associated resistance21,22 may
explain the high recurrence rates that are often associ-
ated with this type of infection. Furthermore, several
virulence factors have been associated with non-albi-
cans Candida strains, such as the ability to adhere and
colonize different substrates (host cells and acrylic sur-
faces), forming mixed biofilm, secretion of degradative
enzymes, and development of drug resistance.28,35,36,57,58
The complex interactions between these 3 species are not
well defined, but the findings from the present study
suggest that a synergistic relationship may be involved,
with the enhanced pathogenic potential of these combina-
tions facilitating the onset of the infection.
In conclusion, non-albicans species were identified
in both healthy and denture stomatitis patients with and
without diabetes. Candida albicans and C. tropicalis
strains were more prevalent in diabetic and nondiabetic
patients with denture stomatitis than in the healthy
OOOOE
732 Sanitá et al. June 2011ones. In patients with severe denture stomatitis, C.
tropicalis was more frequent. The knowledge of prev-
alence species distribution, rapid species identification,
antifungal susceptibility testing and the development of
new antifungal drugs are mandatory to achieve a de-
crease in Candida infections and an increase in quality
of life of denture-wearing individuals with and without
type 2 diabetes mellitus.
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